insights_auto
Why is 207940 up 9.94%?
Dive Deeperchevron_right
207940:KRX
Samsung Biologics Co Ltd
₩1,427,000.00
arrow_upward
+9.94%(+129,000.00) 1D
Oct 19, 3:32:30 PM GMT+9 · KRW
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 207940...
Open
₩1,290,000
High
₩1,432,000
Low
₩1,269,000
Mkt. cap
69.30T
Avg. vol.
49.67K
Volume
151.20K
P/E ratio
31.09
52-wk high
₩1,973,600
52-wk low
₩1,110,460
EPS
₩45,897
Shares outstanding
46.29M
No. of employees
5K
Open
₩1,290,000
High
₩1,432,000
Low
₩1,269,000
Mkt. cap
69.30T
Avg. vol.
49.67K
Volume
151.20K
P/E ratio
31.09
52-wk high
₩1,973,600
52-wk low
₩1,110,460
EPS
₩45,897
Shares outstanding
46.29M
No. of employees
5K
News stories
From web sources and news partners
ad-hoc-news.de
·
20 hours ago
Samsung Biologics clears 87.88% tender hurdle: what it means for Samsung Biologics stock
Profile
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
About Samsung Biologics Co Ltd